Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Lindgren

Showing results (11-20 of 163) with videos related to

Pageof 17
Sort By:
Journal of Cancer Policy|September 10, 2022
Systemic anti-cancer therapy patterns in advanced non-small cell lung cancer in EuropeThomas Hofmarcher, Peter Lindgren, Nils Wilking
International Journal of Technology Assessment in Health Care|April 1, 2009
Modeling the cost-effectiveness of treatment of rheumatoid arthritis with rituximab using registry data from Southern SwedenPeter Lindgren, Pierre Geborek, Gisela Kobelt
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|November 4, 2005
The cost-effectiveness of dual oral antiplatelet therapy following percutaneous coronary intervention: a Swedish analysis of the CREDO trialAnna Ringborg, Peter Lindgren, Bengt Jönsson
Midwifery|February 19, 2013
Midwives' knowledge of, attitudes towards and experiences of caring for women with intellectual disability during pregnancy and childbirth: a cross-sectional study in SwedenBerit Höglund, Peter Lindgren, Margareta Larsson
Orphanet Journal of Rare Diseases|April 4, 2019
Incomplete description of the current body of evidence of the health economics of Duchenne muscular dystrophyErik Landfeldt, Hanns Lochmüller, Peter Lindgren
Frontiers in Medicine|March 9, 2023
A global analysis of the value of precision medicine in oncology - The case of non-small cell lung cancerThomas Hofmarcher, Chiara Malmberg, Peter Lindgren
Current Medical Research and Opinion|June 13, 2008
Cost-effectiveness of clopidogrel treatment in percutaneous coronary intervention: a European model based on a meta-analysis of the PCI-CURE, CREDO and PCI-CLARITY trialsJenny Berg, Dogan Fidan, Peter Lindgren
Midwifery|September 17, 2011
Facts first, then reaction--expectant fathers' experiences of an ultrasound screening identifying soft markersAnnika Åhman, Peter Lindgren, Anna Sarkadi
Acta Obstetricia Et Gynecologica Scandinavica|August 29, 2012
Newborns of mothers with intellectual disability have a higher risk of perinatal death and being small for gestational ageBerit Höglund, Peter Lindgren, Margareta Larsson
Acta Obstetricia Et Gynecologica Scandinavica|August 14, 2012
Pregnancy and birth outcomes of women with intellectual disability in Sweden: a national register studyBerit Höglund, Peter Lindgren, Margareta Larsson
Pageof 17

Showing results (11-20 of 163) with videos related to

Sort By:
Pageof 17
Journal of Cancer Policy|September 10, 2022
Systemic anti-cancer therapy patterns in advanced non-small cell lung cancer in EuropeThomas Hofmarcher, Peter Lindgren, Nils Wilking
International Journal of Technology Assessment in Health Care|April 1, 2009
Modeling the cost-effectiveness of treatment of rheumatoid arthritis with rituximab using registry data from Southern SwedenPeter Lindgren, Pierre Geborek, Gisela Kobelt
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|November 4, 2005
The cost-effectiveness of dual oral antiplatelet therapy following percutaneous coronary intervention: a Swedish analysis of the CREDO trialAnna Ringborg, Peter Lindgren, Bengt Jönsson
Midwifery|February 19, 2013
Midwives' knowledge of, attitudes towards and experiences of caring for women with intellectual disability during pregnancy and childbirth: a cross-sectional study in SwedenBerit Höglund, Peter Lindgren, Margareta Larsson
Orphanet Journal of Rare Diseases|April 4, 2019
Incomplete description of the current body of evidence of the health economics of Duchenne muscular dystrophyErik Landfeldt, Hanns Lochmüller, Peter Lindgren
Frontiers in Medicine|March 9, 2023
A global analysis of the value of precision medicine in oncology - The case of non-small cell lung cancerThomas Hofmarcher, Chiara Malmberg, Peter Lindgren
Current Medical Research and Opinion|June 13, 2008
Cost-effectiveness of clopidogrel treatment in percutaneous coronary intervention: a European model based on a meta-analysis of the PCI-CURE, CREDO and PCI-CLARITY trialsJenny Berg, Dogan Fidan, Peter Lindgren
Midwifery|September 17, 2011
Facts first, then reaction--expectant fathers' experiences of an ultrasound screening identifying soft markersAnnika Åhman, Peter Lindgren, Anna Sarkadi
Acta Obstetricia Et Gynecologica Scandinavica|August 29, 2012
Newborns of mothers with intellectual disability have a higher risk of perinatal death and being small for gestational ageBerit Höglund, Peter Lindgren, Margareta Larsson
Acta Obstetricia Et Gynecologica Scandinavica|August 14, 2012
Pregnancy and birth outcomes of women with intellectual disability in Sweden: a national register studyBerit Höglund, Peter Lindgren, Margareta Larsson
Pageof 17